Hikma Pharmaceuticals plans USD1 billion investment to support US unit
(Alliance News) - Hikma Pharmaceuticals PLC has pledged to invest USD1 billion by 2030 to further expand its US manufacturing and R&D capabilities. Read More
Price | 1,973.00p on 09-07-2025 | at 08:51:03
---|---|
Change | -3.00p -0.15% |
Buy | 1,975.00p |
Sell | 1,973.00p |
Buy / Sell HIK Shares |
Last Trade: | Sell 2.00 at 1,973.00p |
Day's Volume: | 11,482 |
Last Close: | 1,976.00p |
Open: | 1,979.00p |
ISIN: | GB00B0LCW083 |
Day's Range | 1,964.00p - 1,980.00p |
52wk Range: | 1,751.00p - 2,360.00p |
Market Capitalisation: | £4,349m |
VWAP: | 1,971.22436p |
Shares in Issue: | 220m |
Hikma Pharmaceuticals (HIK) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 2 | 1,973.00p | SI Trade |
09:51:03 - 09-Jul-25 |
Buy* | 6 | 1,973.00p | Automatic Execution |
09:49:00 - 09-Jul-25 |
Buy* | 13 | 1,973.00p | Automatic Execution |
09:49:00 - 09-Jul-25 |
Sell* | 417 | 1,971.20p | Negotiated Trade |
09:43:05 - 09-Jul-25 |
Sell* | 2 | 1,971.00p | SI Trade |
09:39:59 - 09-Jul-25 |
Buy* | 57 | 1,972.00p | Automatic Execution |
09:38:55 - 09-Jul-25 |
Sell* | 252 | 1,970.936p | Ordinary |
09:37:05 - 09-Jul-25 |
Sell* | 83 | 1,971.00p | Automatic Execution |
09:36:03 - 09-Jul-25 |
Sell* | 184 | 1,972.00p | Automatic Execution |
09:33:09 - 09-Jul-25 |
Sell* | 56 | 1,972.00p | Automatic Execution |
09:33:09 - 09-Jul-25 |
Hikma Pharmaceuticals (HIK) Regulatory News |
||
Date | Source | Headline |
---|---|---|
7th Jul 2025 9:16 am | RNS | Publication of Offering Circular |
9th Jun 2025 3:33 pm | RNS | Director/PDMR Shareholding |
5th Jun 2025 2:05 pm | RNS | Director/PDMR Shareholding |
3rd Jun 2025 1:02 pm | RNS | Director/PDMR Shareholding |
29th May 2025 7:00 am | RNS | Fitch upgrades Hikma to ‘BBB’ |
20th May 2025 2:49 pm | RNS | Director/PDMR Shareholding |
15th May 2025 12:00 pm | RNS | Medium-term Group guidance ahead of US site visit |
8th May 2025 4:35 pm | RNS | Director/PDMR Shareholding |
8th May 2025 10:48 am | RNS | S&P upgrades Hikma to ‘BBB’ |
8th May 2025 8:21 am | RNS | Settlement agreement for Xyrem® US lawsuits |